These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 6895973)

  • 1. Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers.
    Minami R; Nakamura C; Inotsume N; Nakano M
    Antimicrob Agents Chemother; 1998 Feb; 42(2):453-5. PubMed ID: 9527806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Structure of Sucralfate by Advanced Solid- and Liquid-State NMR.
    Hareendran C; Ravindranathan S; Ajithkumar TG
    Mol Pharm; 2024 Mar; 21(3):1390-1401. PubMed ID: 38329458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ranitidine and sucralfate on ketoconazole bioavailability.
    Piscitelli SC; Goss TF; Wilton JH; D'Andrea DT; Goldstein H; Schentag JJ
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1765-71. PubMed ID: 1952845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of peptic ulcer disease.
    Peppercorn MA
    Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
    Sutphen JL; Dillard VL; Pipan ME
    Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology, clinical efficacy, and adverse effects of sucralfate, a nonsystemic agent for peptic ulcer.
    Spiro HM
    Pharmacotherapy; 1982; 2(2):67-71. PubMed ID: 6927335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
    Borella LE; DiJoseph JF; Mir GN
    Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate--alternative therapy for peptic-ulcer disease.
    Garnett WR
    Clin Pharm; 1982; 1(4):307-14. PubMed ID: 6764389
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.